Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010:3:35-43.
doi: 10.2147/lra.s7709. Epub 2010 Jul 15.

Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery

Affiliations

Review of the efficacy and safety of remifentanil for the prevention and treatment of pain during and after procedures and surgery

Erica L Sivak et al. Local Reg Anesth. 2010.

Abstract

Remifentanil is an ultrashort-acting synthetic opioid. It is metabolized by nonspecific tissue and plasma esterases. Remifentanil's metabolism is responsible for its unique pharmacokinetic profile and flat, context-sensitive half-time. Since its introduction into clinical practice, remifentanil has been used for a variety of anesthetic and analgesic applications; however, concerns regarding a potential for rapid induction of tolerance and/or induced hyperalgesia, coupled with an ultrarapid offset of effect, make the drug less than optimal for use in the pharmacologic management of pain.

Keywords: hyperalgesia; intravenous anesthesia; rapid offset; regional anesthesia; tolerance.

PubMed Disclaimer

References

    1. Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B) Anesth Analg. 1993;77:1031–1040. - PubMed
    1. Jablonka DH, Davis PJ. Opioids in pediatric anesthesia. Anesthesiol Clin North America. 2005;23:621–634. viii. - PubMed
    1. Ross AK, Davis PJ, Dear Gd GL, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg. 2001;93:1393–1401. - PubMed
    1. Egan TD, Lemmens HJ, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 1993;79:881–892. - PubMed
    1. Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995;83:968–975. - PubMed

LinkOut - more resources